DMAC - DiaMedica Therapeutics Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 535.87M
Enterprise Value 320.94M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)71.74
Price/Book (mrq)2.58
Enterprise Value/Revenue 341.87
Enterprise Value/EBITDA 6-2.46

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,703.20%

Management Effectiveness

Return on Assets (ttm)-45.50%
Return on Equity (ttm)-89.45%

Income Statement

Revenue (ttm)500k
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)500k
EBITDA -8.5M
Net Income Avi to Common (ttm)-8.34M
Diluted EPS (ttm)-0.9160
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.72M
Total Cash Per Share (mrq)1.15
Total Debt (mrq)217k
Total Debt/Equity (mrq)1.56
Current Ratio (mrq)10.49
Book Value Per Share (mrq)1.16

Cash Flow Statement

Operating Cash Flow (ttm)-7.89M
Levered Free Cash Flow (ttm)-4.82M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.23
52-Week Change 3-64.38%
S&P500 52-Week Change 34.80%
52 Week High 313.7740
52 Week Low 32.4600
50-Day Moving Average 33.4156
200-Day Moving Average 33.7984

Share Statistics

Avg Vol (3 month) 348.55k
Avg Vol (10 day) 330.93k
Shares Outstanding 511.96M
Float 8.49M
% Held by Insiders 18.37%
% Held by Institutions 113.72%
Shares Short (Apr 30, 2019) 426.12k
Short Ratio (Apr 30, 2019) 40.51
Short % of Float (Apr 30, 2019) 40.24%
Short % of Shares Outstanding (Apr 30, 2019) 40.22%
Shares Short (prior month Mar 29, 2019) 431.17k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A